Aratana Therapeutics, Inc. (Nasdaq: PETX) announced the Company has made NOCITA (bupivacaine liposome injectable suspension) commercially available to veterinarians in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE